Stryker Corporation (SYK)
NYSE: SYK
· Real-Time Price · USD
381.73
3.21 (0.85%)
At close: Aug 15, 2025, 12:05 PM
Stryker Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 30, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedSurg Revenue | 13.52B | 11.84B | 10.61B | 9.54B | 6.4B | 6.57B | 6.04B | 5.56B | 4.89B | 3.9B | 3.78B | 3.36B | 3.27B | 3.16B |
| MedSurg Revenue Growth | +14.21% | +11.54% | +11.25% | +49.03% | -2.65% | +8.75% | +8.78% | +13.55% | +25.65% | +3.02% | +12.56% | +2.88% | +3.32% | n/a |
| Orthopaedics Revenue | 9.08B | n/a | n/a | n/a | 4.96B | 5.25B | 4.99B | 4.71B | 4.42B | 4.22B | 4.15B | 4B | 3.82B | 3.71B |
| Orthopaedics Revenue Growth | n/a | n/a | n/a | n/a | -5.58% | +5.23% | +5.90% | +6.58% | +4.71% | +1.69% | +3.72% | +4.73% | +3.05% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 30, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 2.02B | 1.95B | 1.89B | 1.97B | 1.63B | 1.62B | 1.53B | 9.06B | 1.31B | 1.25B | 1.37B | 1.32B | 1.34B | 1.66B |
| Asia Pacific Revenue Growth | +3.80% | +3.24% | -4.46% | +21.04% | +0.80% | +5.55% | -83.09% | +589.42% | +5.04% | -8.55% | +3.71% | -1.27% | -19.32% | n/a |
| Emea Revenue | 2.9B | 2.62B | 2.35B | 2.3B | 1.82B | 1.89B | 1.79B | 1.41B | 1.44B | 1.27B | 1.37B | 1.32B | 1.27B | n/a |
| Emea Revenue Growth | +10.66% | +11.50% | +2.13% | +26.46% | -3.71% | +5.30% | +26.89% | -2.01% | +13.81% | -7.59% | +4.18% | +3.95% | n/a | n/a |
| Other Foreign Countries Revenue | 735M | 677M | 578M | 515M | 448M | 422M | 428M | n/a | 322M | 312M | 378M | 402M | 397M | n/a |
| Other Foreign Countries Revenue Growth | +8.57% | +17.13% | +12.23% | +14.96% | +6.16% | -1.40% | n/a | n/a | +3.21% | -17.46% | -5.97% | +1.26% | n/a | n/a |
| United States Revenue | 16.94B | 15.26B | 13.64B | 12.32B | 10.46B | 10.96B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +11.05% | +11.87% | +10.69% | +17.85% | -4.58% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.99B | 2.11B | 1.98B | 1.82B | 1.81B | 1.83B | 1.8B | 1.69B | 1.66B | 1.7B | 1.59B | 1.48B | 1.46B | 1.5B | 1.51B | 1.42B | 1.44B | 1.39B | 1.29B | 1.19B | 997M | 1.25B | 1.34B | 1.21B | 1.19B | 1.21B | 1.24B | 1.13B | 1.12B | 1.14B | 1.18B | 1.06B | 1.05B | 1.06B | 1.09B | 987M | 1.04B | 944M | 970M | 887M | 861M | 892M |
| Selling, General, and Administrative Revenue Growth | -5.46% | +6.25% | +8.95% | +0.39% | -1.14% | +1.89% | +6.32% | +2.36% | -2.70% | +6.78% | +7.35% | +1.85% | -2.93% | -0.40% | +6.20% | -1.18% | +3.31% | +7.50% | +9.02% | +18.96% | -19.92% | -6.81% | +10.05% | +1.85% | -1.65% | -2.26% | +9.83% | +0.71% | -1.23% | -3.57% | +11.14% | +0.57% | -0.57% | -3.11% | +10.74% | -5.37% | +10.49% | -2.68% | +9.36% | +3.02% | -3.48% | n/a |
| Research and Development Revenue | 396M | 393M | 342M | 364M | 352M | 356M | 328M | 335M | 319M | 311M | 284M | 317M | 323M | 306M | 331M | 306M | 310M | 288M | 255M | 242M | 233M | 254M | 254M | 246M | 246M | 225M | 221M | 221M | 216M | 204M | 205M | 198M | 192M | 192M | 189M | 184M | 183M | 159M | 164M | 155M | 154M | 152M |
| Research and Development Revenue Growth | +0.76% | +14.91% | -6.04% | +3.41% | -1.12% | +8.54% | -2.09% | +5.02% | +2.57% | +9.51% | -10.41% | -1.86% | +5.56% | -7.55% | +8.17% | -1.29% | +7.64% | +12.94% | +5.37% | +3.86% | -8.27% | 0.00% | +3.25% | 0.00% | +9.33% | +1.81% | 0.00% | +2.31% | +5.88% | -0.49% | +3.54% | +3.12% | 0.00% | +1.59% | +2.72% | +0.55% | +15.09% | -3.05% | +5.81% | +0.65% | +1.32% | n/a |